aluates Reports

$ 0.0

Global Anti-TNF-α Monoclonal Antibody Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-36N7837

Global and China Anti TNF α Monoclonal Antibody Market Insights Forecast to 2027

BUY CHAPTERS

Global Anti-TNF-α Monoclonal Antibody Market Insights, Forecast to 2030

Code: QYRE-Auto-36N7837

Report

December 2024

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbive

Johnson and Johnson

UCB

Anti-TNF-α Monoclonal Antibody Market

The global anti-TNF-α monoclonal antibody market refers to the market for monoclonal antibody drugs targeting tumor necrosis factor-alpha (TNF-α). These antibodies are a type of biologic therapy used in the treatment of inflammatory diseases, primarily autoimmune conditions such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis.

The global Anti-TNF-α Monoclonal Antibody market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global anti-TNF-α monoclonal antibody market is characterized by significant competition, ongoing research, and a wide range of therapeutic options. Advancements in biotechnology and the development of biosimilars contribute to the expanding availability and accessibility of these treatments for patients with inflammatory diseases.

Report Covers:

This report presents an overview of global market for Anti-TNF-α Monoclonal Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Anti-TNF-α Monoclonal Antibody, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anti-TNF-α Monoclonal Antibody, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Anti-TNF-α Monoclonal Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-TNF-α Monoclonal Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anti-TNF-α Monoclonal Antibody sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Anti-TNF-α Monoclonal Antibody Market Report

Report Metric	Details
Report Name	Anti-TNF-α Monoclonal Antibody Market
Segment by Type	Adalimumab Golimumab Infliximab Pecerizumab
Segment by Application	Rheumatoid Arthritis Ankylosing Spondylitis Psoriasis Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	UCB
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Anti-TNF-α Monoclonal Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Anti-TNF-α Monoclonal Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-TNF-α Monoclonal Antibody sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-TNF-α Monoclonal Antibody Market report?

Ans: The main players in the Anti-TNF-α Monoclonal Antibody Market are UCB

What are the Application segmentation covered in the Anti-TNF-α Monoclonal Antibody Market report?

Ans: The Applications covered in the Anti-TNF-α Monoclonal Antibody Market report are Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis, Other

What are the Type segmentation covered in the Anti-TNF-α Monoclonal Antibody Market report?

Ans: The Types covered in the Anti-TNF-α Monoclonal Antibody Market report are Adalimumab, Golimumab, Infliximab, Pecerizumab

1 Study Coverage

1.1 Anti-TNF-α Monoclonal Antibody Product Introduction

1.2 Market by Type

1.2.1 Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Adalimumab

1.2.3 Golimumab

1.2.4 Infliximab

1.2.5 Pecerizumab

1.3 Market by Application

1.3.1 Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Rheumatoid Arthritis

1.3.3 Ankylosing Spondylitis

1.3.4 Psoriasis

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Anti-TNF-α Monoclonal Antibody Sales Estimates and Forecasts 2019-2030

2.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Region

2.2.1 Global Anti-TNF-α Monoclonal Antibody Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2019-2024)

2.2.3 Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2025-2030)

2.2.4 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2019-2030)

2.3 Global Anti-TNF-α Monoclonal Antibody Sales Estimates and Forecasts 2019-2030

2.4 Global Anti-TNF-α Monoclonal Antibody Sales by Region

2.4.1 Global Anti-TNF-α Monoclonal Antibody Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Anti-TNF-α Monoclonal Antibody Sales by Region (2019-2024)

2.4.3 Global Anti-TNF-α Monoclonal Antibody Sales by Region (2025-2030)

2.4.4 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Anti-TNF-α Monoclonal Antibody Sales by Manufacturers

3.1.1 Global Anti-TNF-α Monoclonal Antibody Sales by Manufacturers (2019-2024)

3.1.2 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-TNF-α Monoclonal Antibody in 2023

3.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Manufacturers

3.2.1 Global Anti-TNF-α Monoclonal Antibody Revenue by Manufacturers (2019-2024)

3.2.2 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Anti-TNF-α Monoclonal Antibody Revenue in 2023

3.3 Global Key Players of Anti-TNF-α Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Anti-TNF-α Monoclonal Antibody Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Anti-TNF-α Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Product Offered and Application

3.8 Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Anti-TNF-α Monoclonal Antibody Sales by Type

4.1.1 Global Anti-TNF-α Monoclonal Antibody Historical Sales by Type (2019-2024)

4.1.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Sales by Type (2025-2030)

4.1.3 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2019-2030)

4.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Type

4.2.1 Global Anti-TNF-α Monoclonal Antibody Historical Revenue by Type (2019-2024)

4.2.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Revenue by Type (2025-2030)

4.2.3 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2019-2030)

4.3 Global Anti-TNF-α Monoclonal Antibody Price by Type

4.3.1 Global Anti-TNF-α Monoclonal Antibody Price by Type (2019-2024)

4.3.2 Global Anti-TNF-α Monoclonal Antibody Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Anti-TNF-α Monoclonal Antibody Sales by Application

5.1.1 Global Anti-TNF-α Monoclonal Antibody Historical Sales by Application (2019-2024)

5.1.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Sales by Application (2025-2030)

5.1.3 Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2019-2030)

5.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Application

5.2.1 Global Anti-TNF-α Monoclonal Antibody Historical Revenue by Application (2019-2024)

5.2.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Revenue by Application (2025-2030)

5.2.3 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2019-2030)

5.3 Global Anti-TNF-α Monoclonal Antibody Price by Application

5.3.1 Global Anti-TNF-α Monoclonal Antibody Price by Application (2019-2024)

5.3.2 Global Anti-TNF-α Monoclonal Antibody Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Anti-TNF-α Monoclonal Antibody Market Size by Type

6.1.1 US & Canada Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2030)

6.1.2 US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2030)

6.2 US & Canada Anti-TNF-α Monoclonal Antibody Market Size by Application

6.2.1 US & Canada Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2030)

6.2.2 US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2030)

6.3 US & Canada Anti-TNF-α Monoclonal Antibody Market Size by Country

6.3.1 US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Anti-TNF-α Monoclonal Antibody Sales by Country (2019-2030)

6.3.3 US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Anti-TNF-α Monoclonal Antibody Market Size by Type

7.1.1 Europe Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2030)

7.1.2 Europe Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2030)

7.2 Europe Anti-TNF-α Monoclonal Antibody Market Size by Application

7.2.1 Europe Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2030)

7.2.2 Europe Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2030)

7.3 Europe Anti-TNF-α Monoclonal Antibody Market Size by Country

7.3.1 Europe Anti-TNF-α Monoclonal Antibody Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2019-2030)

7.3.3 Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Anti-TNF-α Monoclonal Antibody Market Size

8.1.1 China Anti-TNF-α Monoclonal Antibody Sales (2019-2030)

8.1.2 China Anti-TNF-α Monoclonal Antibody Revenue (2019-2030)

8.2 China Anti-TNF-α Monoclonal Antibody Market Size by Application

8.2.1 China Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2030)

8.2.2 China Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Anti-TNF-α Monoclonal Antibody Market Size by Type

9.1.1 Asia Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2030)

9.1.2 Asia Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2030)

9.2 Asia Anti-TNF-α Monoclonal Antibody Market Size by Application

9.2.1 Asia Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2030)

9.2.2 Asia Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2030)

9.3 Asia Anti-TNF-α Monoclonal Antibody Sales by Region

9.3.1 Asia Anti-TNF-α Monoclonal Antibody Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Anti-TNF-α Monoclonal Antibody Revenue by Region (2019-2030)

9.3.3 Asia Anti-TNF-α Monoclonal Antibody Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Market Size by Type

10.1.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Market Size by Application

10.2.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Country

10.3.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Abbive

11.1.1 Abbive Company Information

11.1.2 Abbive Overview

11.1.3 Abbive Anti-TNF-α Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Abbive Anti-TNF-α Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Abbive Recent Developments

11.2 Johnson and Johnson

11.2.1 Johnson and Johnson Company Information

11.2.2 Johnson and Johnson Overview

11.2.3 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Johnson and Johnson Recent Developments

11.3 UCB

11.3.1 UCB Company Information

11.3.2 UCB Overview

11.3.3 UCB Anti-TNF-α Monoclonal Antibody Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 UCB Anti-TNF-α Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 UCB Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Anti-TNF-α Monoclonal Antibody Industry Chain Analysis

12.2 Anti-TNF-α Monoclonal Antibody Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Anti-TNF-α Monoclonal Antibody Production Mode & Process

12.4 Anti-TNF-α Monoclonal Antibody Sales and Marketing

12.4.1 Anti-TNF-α Monoclonal Antibody Sales Channels

12.4.2 Anti-TNF-α Monoclonal Antibody Distributors

12.5 Anti-TNF-α Monoclonal Antibody Customers

13 Market Dynamics

13.1 Anti-TNF-α Monoclonal Antibody Industry Trends

13.2 Anti-TNF-α Monoclonal Antibody Market Drivers

13.3 Anti-TNF-α Monoclonal Antibody Market Challenges

13.4 Anti-TNF-α Monoclonal Antibody Market Restraints

14 Key Findings in The Global Anti-TNF-α Monoclonal Antibody Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Abbive

Johnson and Johnson

UCB

List of Tables

Table 1. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Adalimumab

Table 3. Major Manufacturers of Golimumab

Table 4. Major Manufacturers of Infliximab

Table 5. Major Manufacturers of Pecerizumab

Table 6. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Anti-TNF-α Monoclonal Antibody Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2025-2030) & (US$ Million)

Table 10. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2019-2024)

Table 11. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2025-2030)

Table 12. Global Anti-TNF-α Monoclonal Antibody Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 13. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2019-2024) & (KG)

Table 14. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2025-2030) & (KG)

Table 15. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2019-2024)

Table 16. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2025-2030)

Table 17. Global Anti-TNF-α Monoclonal Antibody Sales by Manufacturers (2019-2024) & (KG)

Table 18. Global Anti-TNF-α Monoclonal Antibody Sales Share by Manufacturers (2019-2024)

Table 19. Global Anti-TNF-α Monoclonal Antibody Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 20. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Manufacturers (2019-2024)

Table 21. Global Key Players of Anti-TNF-α Monoclonal Antibody, Industry Ranking, 2022 VS 2023 VS 2024

Table 22. Anti-TNF-α Monoclonal Antibody Price by Manufacturers 2019-2024 (USD/KG)

Table 23. Global Anti-TNF-α Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Anti-TNF-α Monoclonal Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TNF-α Monoclonal Antibody as of 2023)

Table 25. Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Product Offered and Application

Table 27. Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2024) & (KG)

Table 30. Global Anti-TNF-α Monoclonal Antibody Sales by Type (2025-2030) & (KG)

Table 31. Global Anti-TNF-α Monoclonal Antibody Sales Share by Type (2019-2024)

Table 32. Global Anti-TNF-α Monoclonal Antibody Sales Share by Type (2025-2030)

Table 33. Global Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)

Table 34. Global Anti-TNF-α Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)

Table 35. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Type (2019-2024)

Table 36. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Type (2025-2030)

Table 37. Anti-TNF-α Monoclonal Antibody Price by Type (2019-2024) & (USD/KG)

Table 38. Global Anti-TNF-α Monoclonal Antibody Price Forecast by Type (2025-2030) & (USD/KG)

Table 39. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2024) & (KG)

Table 40. Global Anti-TNF-α Monoclonal Antibody Sales by Application (2025-2030) & (KG)

Table 41. Global Anti-TNF-α Monoclonal Antibody Sales Share by Application (2019-2024)

Table 42. Global Anti-TNF-α Monoclonal Antibody Sales Share by Application (2025-2030)

Table 43. Global Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)

Table 44. Global Anti-TNF-α Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)

Table 45. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Application (2019-2024)

Table 46. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Application (2025-2030)

Table 47. Anti-TNF-α Monoclonal Antibody Price by Application (2019-2024) & (USD/KG)

Table 48. Global Anti-TNF-α Monoclonal Antibody Price Forecast by Application (2025-2030) & (USD/KG)

Table 49. US & Canada Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2024) & (KG)

Table 50. US & Canada Anti-TNF-α Monoclonal Antibody Sales by Type (2025-2030) & (KG)

Table 51. US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)

Table 52. US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)

Table 53. US & Canada Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2024) & (KG)

Table 54. US & Canada Anti-TNF-α Monoclonal Antibody Sales by Application (2025-2030) & (KG)

Table 55. US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)

Table 56. US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)

Table 57. US & Canada Anti-TNF-α Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 58. US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)

Table 59. US & Canada Anti-TNF-α Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)

Table 60. US & Canada Anti-TNF-α Monoclonal Antibody Sales by Country (2019-2024) & (KG)

Table 61. US & Canada Anti-TNF-α Monoclonal Antibody Sales by Country (2025-2030) & (KG)

Table 62. Europe Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2024) & (KG)

Table 63. Europe Anti-TNF-α Monoclonal Antibody Sales by Type (2025-2030) & (KG)

Table 64. Europe Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)

Table 65. Europe Anti-TNF-α Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)

Table 66. Europe Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2024) & (KG)

Table 67. Europe Anti-TNF-α Monoclonal Antibody Sales by Application (2025-2030) & (KG)

Table 68. Europe Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)

Table 69. Europe Anti-TNF-α Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)

Table 70. Europe Anti-TNF-α Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 71. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)

Table 72. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)

Table 73. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2019-2024) & (KG)

Table 74. Europe Anti-TNF-α Monoclonal Antibody Sales by Country (2025-2030) & (KG)

Table 75. China Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2024) & (KG)

Table 76. China Anti-TNF-α Monoclonal Antibody Sales by Type (2025-2030) & (KG)

Table 77. China Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)

Table 78. China Anti-TNF-α Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)

Table 79. China Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2024) & (KG)

Table 80. China Anti-TNF-α Monoclonal Antibody Sales by Application (2025-2030) & (KG)

Table 81. China Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)

Table 82. China Anti-TNF-α Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)

Table 83. Asia Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2024) & (KG)

Table 84. Asia Anti-TNF-α Monoclonal Antibody Sales by Type (2025-2030) & (KG)

Table 85. Asia Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)

Table 86. Asia Anti-TNF-α Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)

Table 87. Asia Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2024) & (KG)

Table 88. Asia Anti-TNF-α Monoclonal Antibody Sales by Application (2025-2030) & (KG)

Table 89. Asia Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)

Table 90. Asia Anti-TNF-α Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)

Table 91. Asia Anti-TNF-α Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 92. Asia Anti-TNF-α Monoclonal Antibody Revenue by Region (2019-2024) & (US$ Million)

Table 93. Asia Anti-TNF-α Monoclonal Antibody Revenue by Region (2025-2030) & (US$ Million)

Table 94. Asia Anti-TNF-α Monoclonal Antibody Sales by Region (2019-2024) & (KG)

Table 95. Asia Anti-TNF-α Monoclonal Antibody Sales by Region (2025-2030) & (KG)

Table 96. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Type (2019-2024) & (KG)

Table 97. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Type (2025-2030) & (KG)

Table 98. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Type (2019-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Type (2025-2030) & (US$ Million)

Table 100. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Application (2019-2024) & (KG)

Table 101. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Application (2025-2030) & (KG)

Table 102. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Application (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Application (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 105. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country (2019-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country (2025-2030) & (US$ Million)

Table 107. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2019-2024) & (KG)

Table 108. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Country (2025-2030) & (KG)

Table 109. Abbive Company Information

Table 110. Abbive Description and Major Businesses

Table 111. Abbive Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)

Table 112. Abbive Anti-TNF-α Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Abbive Recent Developments

Table 114. Johnson and Johnson Company Information

Table 115. Johnson and Johnson Description and Major Businesses

Table 116. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)

Table 117. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Johnson and Johnson Recent Developments

Table 119. UCB Company Information

Table 120. UCB Description and Major Businesses

Table 121. UCB Anti-TNF-α Monoclonal Antibody Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2019-2024)

Table 122. UCB Anti-TNF-α Monoclonal Antibody Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. UCB Recent Developments

Table 124. Key Raw Materials Lists

Table 125. Raw Materials Key Suppliers Lists

Table 126. Anti-TNF-α Monoclonal Antibody Distributors List

Table 127. Anti-TNF-α Monoclonal Antibody Customers List

Table 128. Anti-TNF-α Monoclonal Antibody Market Trends

Table 129. Anti-TNF-α Monoclonal Antibody Market Drivers

Table 130. Anti-TNF-α Monoclonal Antibody Market Challenges

Table 131. Anti-TNF-α Monoclonal Antibody Market Restraints

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-TNF-α Monoclonal Antibody Product Picture

Figure 2. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-TNF-α Monoclonal Antibody Market Share by Type in 2023 & 2030

Figure 4. Adalimumab Product Picture

Figure 5. Golimumab Product Picture

Figure 6. Infliximab Product Picture

Figure 7. Pecerizumab Product Picture

Figure 8. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Anti-TNF-α Monoclonal Antibody Market Share by Application in 2023 & 2030

Figure 10. Rheumatoid Arthritis

Figure 11. Ankylosing Spondylitis

Figure 12. Psoriasis

Figure 13. Other

Figure 14. Anti-TNF-α Monoclonal Antibody Report Years Considered

Figure 15. Global Anti-TNF-α Monoclonal Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Anti-TNF-α Monoclonal Antibody Revenue 2019-2030 (US$ Million)

Figure 17. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2019-2030)

Figure 19. Global Anti-TNF-α Monoclonal Antibody Sales 2019-2030 ((KG)

Figure 20. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Anti-TNF-α Monoclonal Antibody Sales YoY (2019-2030) & (KG)

Figure 22. US & Canada Anti-TNF-α Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Anti-TNF-α Monoclonal Antibody Sales YoY (2019-2030) & (KG)

Figure 24. Europe Anti-TNF-α Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Anti-TNF-α Monoclonal Antibody Sales YoY (2019-2030) & (KG)

Figure 26. China Anti-TNF-α Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Anti-TNF-α Monoclonal Antibody Sales YoY (2019-2030) & (KG)

Figure 28. Asia (excluding China) Anti-TNF-α Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales YoY (2019-2030) & (KG)

Figure 30. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Anti-TNF-α Monoclonal Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Anti-TNF-α Monoclonal Antibody in the World: Market Share by Anti-TNF-α Monoclonal Antibody Revenue in 2023

Figure 33. Global Anti-TNF-α Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2019-2030)

Figure 35. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2019-2030)

Figure 36. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2019-2030)

Figure 37. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Anti-TNF-α Monoclonal Antibody Revenue Share by Country (2019-2030)

Figure 43. US & Canada Anti-TNF-α Monoclonal Antibody Sales Share by Country (2019-2030)

Figure 44. U.S. Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2019-2030)

Figure 47. Europe Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2019-2030)

Figure 48. Europe Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2019-2030)

Figure 49. Europe Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2019-2030)

Figure 50. Europe Anti-TNF-α Monoclonal Antibody Revenue Share by Country (2019-2030)

Figure 51. Europe Anti-TNF-α Monoclonal Antibody Sales Share by Country (2019-2030)

Figure 52. Germany Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 53. France Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 57. China Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2019-2030)

Figure 58. China Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2019-2030)

Figure 59. China Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2019-2030)

Figure 60. China Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2019-2030)

Figure 61. Asia Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2019-2030)

Figure 62. Asia Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2019-2030)

Figure 63. Asia Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2019-2030)

Figure 64. Asia Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2019-2030)

Figure 65. Asia Anti-TNF-α Monoclonal Antibody Revenue Share by Region (2019-2030)

Figure 66. Asia Anti-TNF-α Monoclonal Antibody Sales Share by Region (2019-2030)

Figure 67. Japan Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 71. India Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Share by Country (2019-2030)

Figure 78. Brazil Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Anti-TNF-α Monoclonal Antibody Revenue (2019-2030) & (US$ Million)

Figure 83. Anti-TNF-α Monoclonal Antibody Value Chain

Figure 84. Anti-TNF-α Monoclonal Antibody Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmaceutical Labelling Machine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13D10320

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Pharmaceutical Industry Thermal Transfer Overprinting (TTO) Equipment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27N15076

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Pharmaceutical Strip Packaging Machines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36X10626

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Triclopyr Acid Technical Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37A19019

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions